SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001126234-14-000116
Filing Date
2014-05-08
Accepted
2014-05-08 14:21:34
Documents
11
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 MARCH 2014 10-Q nlnk-20140331x10q.htm 10-Q 842006
2 CEO CERTIFICATION nlnk-20140331xex311.htm EX-31.1 12293
3 CFO CERTIFICATION nlnk-20140331xex312.htm EX-31.2 12436
4 SECTION 1350 CERTIFICATION nlnk-20140331xex321.htm EX-32.1 8676
11 GRAPHIC logo20130930a01a01.jpg GRAPHIC 20255
  Complete submission text file 0001126234-14-000116.txt   3443369

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT nlnk-20140331.xml EX-101.INS 287268
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nlnk-20140331.xsd EX-101.SCH 27768
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT nlnk-20140331_cal.xml EX-101.CAL 48156
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT nlnk-20140331_def.xml EX-101.DEF 160109
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nlnk-20140331_lab.xml EX-101.LAB 388006
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nlnk-20140331_pre.xml EX-101.PRE 200612
Mailing Address 2503 SOUTH LOOP DRIVE SUITE 5100 AMES IA 50010
Business Address 2503 SOUTH LOOP DRIVE SUITE 5100 AMES IA 50010 515-296-5555
NEWLINK GENETICS CORP (Filer) CIK: 0001126234 (see all company filings)

IRS No.: 421491350 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35342 | Film No.: 14824310
SIC: 2834 Pharmaceutical Preparations